LBA14 First-in-human phase I study of GTA182, a novel MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted advanced non-small cell lung cancer
作者
S. Lu,X. Ai,Xianjun Yu,J. Zhang,Y. Zhao,D. Lv,N. Li,Z. Song,J. L. Shi,L. Zhuang,L. Wu,M. Qin,L. Zeng,James D. Joseph,Fred Aswad,Mingxi Li
出处
期刊:Annals of Oncology [Elsevier BV] 日期:2025-12-01卷期号:36: S2048-S2048被引量:1